26.12.2012 Views

IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC ...

IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC ...

IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

246<br />

In a large cohort study in Shanghai, China, risk for hepatocellular carcinoma was<br />

elevated among people with aflatoxin metabolites in urine, after adjustment for cigarette<br />

smoking and hepatitis B surface antigen positivity. No association was observed between<br />

dietary aflatoxin levels, as ascertained by a diet frequency questionnaire, and risk for<br />

hepatocellular carcinoma.<br />

There were four reports from cohort studies in Taiwan, China, although three of them<br />

partly overlapped. Selected subjects in the three overlapping studies were enrolled, were<br />

interviewed, had biological specimens taken, and were followed up intensively for liver<br />

cancer. In nested case–control studies, including some prevalent cases, subjects with<br />

exposure to aflatoxin, as assessed by biomarker measurements, had elevated risks for<br />

liver cancer, after adjustment for hepatitis B surface antigen positivity. The effect due to<br />

aflatoxin exposure was especially high among those who were positive for hepatitis B<br />

surface antigen, but there were few liver cancer cases negative for hepatitis B surface<br />

antigen. The other Taiwan study was carried out in a large cohort of chronic carriers of<br />

hepatitis B virus. These subjects were interviewed at baseline, had biological specimens<br />

taken, and were followed up intensively for liver cancer. Several aflatoxin metabolites<br />

and albumin adducts were measured in a nested case–control series. Subjects with quantified<br />

levels of most of the biomarkers of exposure to aflatoxin showed elevated risk for<br />

liver cancer.<br />

In two studies in Qidong, China, cohorts of hepatitis B carriers were tested for biomarkers<br />

of aflatoxin and followed up for liver cancer. In both studies, subjects with aflatoxin<br />

biomarkers had excess risks for liver cancer.<br />

In a Sudanese case–control study of liver cancer, a relationship was found between<br />

reported ingestion of peanut butter and liver cancer in a region with high aflatoxin contamination<br />

of peanuts, but no such relationship in a region with low contamination of<br />

peanuts.<br />

In a hybrid ecological cross-sectional study in Taiwan, China, a number of subjects<br />

were selected from eight regions; for each subject several biomarkers of aflatoxin and<br />

hepatitis B viral infection were assessed in relation to the liver cancer rates in the region<br />

of residence. There were correlations between aflatoxin metabolites and liver cancer<br />

rates after adjustment for hepatitis B status.<br />

The overall body of evidence supports a role of aflatoxins in liver cancer etiology,<br />

notably among subjects who are carriers of hepatitis B surface antigen. Nevertheless, the<br />

interpretation of human studies is hampered by the difficulties in properly assessing an<br />

individual’s lifetime exposure to aflatoxins and the difficulties in disentangling the<br />

effects of aflatoxins from those of hepatitis infections. Novel biomarkers, some still<br />

under development and validation, should bring greater clarity to the issue.<br />

5.3 Animal carcinogenicity data<br />

<strong>IARC</strong> <strong>M<strong>ON</strong>OGRAPHS</strong> VOLUME 82<br />

Extensive experimental studies on the carcinogenicity of aflatoxins led to a previous<br />

<strong>IARC</strong> Monographs evaluation of the evidence as follows: sufficient evidence for carcino-

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!